No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs371568681 |
chr4:7980413-7980414 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs559210036 |
chr4:7980446-7980447 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs34457410 |
chr4:7980451-7980452 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs538332903 |
chr4:7980469-7980470 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs553419595 |
chr4:7980472-7980473 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs571733395 |
chr4:7980500-7980501 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs542167230 |
chr4:7980563-7980564 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs558291960 |
chr4:7980612-7980613 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs80235495 |
chr4:7980637-7980638 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs7699704 |
chr4:7980639-7980640 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs7699715 |
chr4:7980652-7980653 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
12 |
rs190954828 |
chr4:7980653-7980654 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs548419789 |
chr4:7980655-7980656 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs570530560 |
chr4:7980709-7980710 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs1878323 |
chr4:7980725-7980726 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs530126782 |
chr4:7980732-7980733 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs11734838 |
chr4:7980737-7980738 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs112327867 |
chr4:7980746-7980747 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs537729360 |
chr4:7980750-7980751 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs552533418 |
chr4:7980752-7980753 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs537951663 |
chr4:7980783-7980784 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs111668469 |
chr4:7980822-7980823 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs571042551 |
chr4:7980831-7980832 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs150648856 |
chr4:7980880-7980881 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs553450447 |
chr4:7980886-7980887 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs571765784 |
chr4:7980903-7980904 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs368362078 |
chr4:7980940-7980941 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs535887192 |
chr4:7980969-7980970 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs538705964 |
chr4:7980971-7980972 |
Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|